| Original language | English |
|---|---|
| Pages (from-to) | 137-144 |
| Number of pages | 8 |
| Journal | Clinical Cardiology |
| Volume | 39 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2016 |
Cite this
Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement after Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial. / Nissen, Steven E.; Dent-Acosta, Ricardo E.; Rosenson, Robert S.; Stroes, Erik S.; Sattar, N.; Preiss, David; Mancini, G. B John; Ballantyne, Christie M.; Catapano, A.; Gouni-Berthold, Ioanna; Stein, E. A.; Xue, Allen; Wasserman, Scott M.; Scott, R.; Thompson, P. D.
In: Clinical Cardiology, Vol. 39, No. 3, 2016, p. 137-144.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement after Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial
AU - Nissen, Steven E.
AU - Dent-Acosta, Ricardo E.
AU - Rosenson, Robert S.
AU - Stroes, Erik S.
AU - Sattar, N.
AU - Preiss, David
AU - Mancini, G. B John
AU - Ballantyne, Christie M.
AU - Catapano, A.
AU - Gouni-Berthold, Ioanna
AU - Stein, E. A.
AU - Xue, Allen
AU - Wasserman, Scott M.
AU - Scott, R.
AU - Thompson, P. D.
N1 - Cited By :3 Export Date: 5 April 2017
PY - 2016
Y1 - 2016
U2 - 10.1002/clc.22518
DO - 10.1002/clc.22518
M3 - Article
VL - 39
SP - 137
EP - 144
JO - Clinical Cardiology
JF - Clinical Cardiology
SN - 0160-9289
IS - 3
ER -